Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;57(1):113-115.
doi: 10.1038/s41409-021-01484-7. Epub 2021 Oct 5.

Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma?

Affiliations

Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma?

Thomas Millard et al. Bone Marrow Transplant. 2022 Jan.
No abstract available

PubMed Disclaimer

References

    1. Korfel A, Schlegel U. Diagnosis and treatment of primary CNS lymphoma. Nat Rev Neurol. 2013;9:317–27. https://doi.org/10.1038/nrneurol.2013.83 . - DOI - PubMed
    1. Fox CP, Phillips EH, Smith J, Linton K, Gallop-Evans E, Hemmaway C, et al. Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma. Br J Haematol. 2019;184:348–63. https://doi.org/10.1111/bjh.15661 . - DOI - PubMed
    1. Prica A, Chan K, Cheung MC. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis. Br J Haematol. 2012;158:600–7. https://doi.org/10.1111/j.1365-2141.2012.09208.x . - DOI - PubMed
    1. Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Rosée P, et al. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. Lancet Haematol. 2017;4:e510–23. https://doi.org/10.1016/S2352-3026(17)30174-6 . - DOI - PubMed
    1. Cunningham J, Iyengar S, Sharma B. Evolution of lymphoma staging and response evaluation: current limitations and future directions. Nat Rev Clin Oncol. 2017;14:631–45. https://doi.org/10.1038/nrclinonc.2017.78 . - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources